Hypoxia as a risk factor for doxorubicin-induced cardiotoxicity: A NMR evaluation

Previous studies suggested that one possible mechanism of doxorubicin (DXR)-induced cardiomyopathy involves the depletion of high-energy phosphate stores. In this study, we used 31P nuclear magnetic resonance to assess the high-energy phosphate content in Langendorff perfused rat hearts. Hearts were...

Full description

Saved in:
Bibliographic Details
Published inBiochemical and biophysical research communications Vol. 163; no. 2; pp. 682 - 688
Main Authors Bradamante, S., Monti, E., Paracchini, L., Perletti, G.
Format Journal Article
LanguageEnglish
Published San Diego, CA Elsevier Inc 15.09.1989
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Previous studies suggested that one possible mechanism of doxorubicin (DXR)-induced cardiomyopathy involves the depletion of high-energy phosphate stores. In this study, we used 31P nuclear magnetic resonance to assess the high-energy phosphate content in Langendorff perfused rat hearts. Hearts were perfused in normoxic conditions (spontaneous flow) or in partially hypoxic conditions obtained by perfusing at 50% of the spontaneous flow. DXR was used at the subtoxic conditions of 50 mg/l for 15 min and at the cardiotoxic concentration of 100 mg/l for 60 min. Left ventricular pressure (dP/dt), heart rate, myocardial ATP and PCr levels andPCr/ATP ratio were measured. We found that, in normoxic conditons, DXR (50 mg/l, 15 min) does not impair cellular high-energy phosphate metabolism. However, in mild hypoxic conditions, DXR induces a significant decrease inPCr/ATP ratio, due to a decrease in PCr and to a simultaneous increase in ATP. Similar results are obtained after 60 min perfusion with the cardiotoxic dose of DXR. This study suggests that hypoxia may represent a risk factor for the development of DXR-induced acute cardiotoxicity.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0006-291X
1090-2104
DOI:10.1016/0006-291X(89)92277-8